Just a moment, the page is loading...
The Supported Studies Programme
×


6 Results:


Sponsor Postings ↑ Description Created
 
Belimumab + immunology and specialty medicine Currently accepting belimumab ISS proposals, with next review committee in February 2018 8/22/2017
 
Classic & Established (Marketed) 4/1/2019
 
Consumer Health 4/1/2019
 
Oncology 4/1/2019
 
Respiratory 4/1/2019
 
Vaccines 4/1/2019
© 2001-2020 GlaxoSmithKline plc. All rights reserved. Registered in England and Wales No. 3888792.
Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.